Prognostic Value of Tissue Inhibitor of Metalloproteinase-2 Expression in Patients with Non–Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Value of Tissue Inhibitor of Metalloproteinase-2 Expression in Patients with Non–Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Authors
Keywords
Non-small cell lung cancer, Meta-analysis, Immunohistochemistry techniques, Prognosis, Publication ethics, Database searching, Systematic reviews, Chinese people
Journal
PLoS One
Volume 10, Issue 4, Pages e0124230
Publisher
Public Library of Science (PLoS)
Online
2015-04-24
DOI
10.1371/journal.pone.0124230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGF-β1 Protein Expression in Non-Small Cell Lung Cancers is Correlated with Prognosis
- (2014) Ai-Li Huang et al. Asian Pacific Journal of Cancer Prevention
- Significance of circulating matrix metalloproteinase-9 to tissue inhibitor of metalloproteinases-2 ratio as a predictor of disease progression in patients with metastatic renal cell carcinoma receiving sunitinib11This study was partially supported by Pfizer Inc.
- (2014) Hideaki Miyake et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A novel compound RY10-4 induces apoptosis and inhibits invasion via inhibiting STAT3 through ERK-, p38-dependent pathways in human lung adenocarcinoma A549 cells
- (2013) Pingping Xue et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Genes and Pathology of Non-Small Cell Lung Carcinoma
- (2013) Shingo Sakashita et al. SEMINARS IN ONCOLOGY
- Loss of TIMP-3 Promotes Tumor Invasion via Elevated IL-6 Production and Predicts Poor Survival and Relapse in HPV-Infected Non–Small Cell Lung Cancer
- (2012) De-Wei Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Downregulation of Cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9
- (2012) Zhe Qian et al. BMC CANCER
- Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer
- (2012) Wen-Jia Peng et al. CLINICA CHIMICA ACTA
- TIMP-2 Targets Tumor-associated Myeloid Suppressor Cells With Effects in Cancer Immune Dysfunction and Angiogenesis
- (2012) Liliana Guedez et al. JOURNAL OF IMMUNOTHERAPY
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
- (2011) M. Grunnet et al. LUNG CANCER
- Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential
- (2011) Netta Sela-Passwell et al. NATURE MEDICINE
- The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis
- (2010) Qian Qian et al. CANCER INVESTIGATION
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer☆☆☆
- (2009) Virginia Tirino et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Three Immunomarker Support Vector Machines–Based Prognostic Classifiers for Stage IB Non–Small-Cell Lung Cancer
- (2009) Zhi-Hua Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started